{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T12:51:21Z","timestamp":1776862281719,"version":"3.51.2"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejcancer.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.ejca.2013.10.019","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T03:49:16Z","timestamp":1385005756000},"page":"602-610","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Conditional survival of malignant melanoma in The Netherlands: 1994\u20132008"],"prefix":"10.1016","volume":"50","author":[{"given":"Robert J.T.","family":"van der Leest","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liza N.","family":"van Steenbergen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loes M.","family":"Hollestein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamar","family":"Nijsten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander C.J.","family":"van Akkooi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryska L.G.","family":"Janssen-Heijnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan-Willem W.","family":"Coebergh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2013.10.019_b0005","unstructured":"Comprehensive Cancer Centre Netherlands, <http:\/\/cijfersoverkanker.nl>; 2013 [accessed on 31 May 2013]."},{"key":"10.1016\/j.ejca.2013.10.019_b0010","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ijc.27616","article-title":"International trends in the incidence of malignant melanoma 1953\u20132008 \u2013 are recent generations at higher or lower risk?","volume":"132","author":"Erdmann","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2013.10.019_b0015","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1177\/1403494813479216","article-title":"Cutaneous malignant melanoma incidence rates in Norway","volume":"41","author":"Moan","year":"2013","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.ejca.2013.10.019_b0020","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.ejca.2007.12.015","article-title":"Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s","volume":"44","author":"Karim-Kos","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2013.10.019_b0025","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0140-6736(02)09779-9","article-title":"Incidence of and survival from malignant melanoma in Scotland: an epidemiological study","volume":"360","author":"MacKie","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2013.10.019_b0030","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/ijc.23495","article-title":"Trends in prognostic factors and survival from cutaneous melanoma in Yorkshire, UK and New South Wales, Australia between 1993 and 2003","volume":"123","author":"Downing","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2013.10.019_b0035","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1467-842X.2005.tb00211.x","article-title":"Trends in melanoma mortality in Australia: 1950\u20132002 and their implications for melanoma control","volume":"29","author":"Baade","year":"2005","journal-title":"Aust N Z J Public Health"},{"key":"10.1016\/j.ejca.2013.10.019_b0040","doi-asserted-by":"crossref","first-page":"a2249","DOI":"10.1136\/bmj.a2249","article-title":"Melanoma\u2013Part 1: epidemiology, risk factors, and prevention","volume":"337","author":"Bataille","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.ejca.2013.10.019_b0045","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.clindermatol.2009.06.021","article-title":"Melanoma epidemic: facts and controversies","volume":"28","author":"Erickson","year":"2010","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.ejca.2013.10.019_b0050","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3109\/02841861003702528","article-title":"Trends in the survival of patients diagnosed with malignant melanoma of the skin in the Nordic countries 1964\u20132003 followed up to the end of 2006","volume":"49","author":"Tryggvadottir","year":"2010","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejca.2013.10.019_b0055","unstructured":"NORDCAN, <http:\/\/www-dep.iarc.fr\/NORDCAN\/english\/frame.asp>; 2013 [accessed 18th October 2013]."},{"key":"10.1016\/j.ejca.2013.10.019_b0060","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.ejca.2011.11.030","article-title":"Socio-economic implications of cancer survivorship: Results from the PROFILES registry","volume":"48","author":"Mols","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2013.10.019_b0065","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1200\/JCO.2009.25.9697","article-title":"Clinical relevance of conditional survival of cancer patients in europe: age-specific analyses of 13 cancers","volume":"28","author":"Janssen-Heijnen","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2013.10.019_b0070","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.ejca.2008.11.018","article-title":"EUROCARE-4. Survival of cancer patients diagnosed in 1995\u20131999. Results and commentary","volume":"45","author":"Sant","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2013.10.019_b0075","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/annonc\/mdm127","article-title":"Prognosis for long-term survivors of cancer","volume":"18","author":"Janssen-Heijnen","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2013.10.019_b0080","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1186\/1471-2407-12-460","article-title":"Conditional survival of cancer patients: an Australian perspective","volume":"12","author":"Yu","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejca.2013.10.019_b0085","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1002\/cncr.24966","article-title":"Conditional survival estimates improve over time for patients with advanced melanoma: results from a population-based analysis","volume":"116","author":"Xing","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2013.10.019_b0090","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1245\/s10434-010-1051-y","article-title":"Conditional survival estimates improve over 5 years for melanoma survivors with node-positive disease","volume":"17","author":"Bowles","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2013.10.019_b0095","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1245\/s10434-010-0965-8","article-title":"Conditional survival after surgical treatment of melanoma: an analysis of the Surveillance, Epidemiology, and End Results database","volume":"17","author":"Rueth","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2013.10.019_b0100","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1634\/theoncologist.2009-0211","article-title":"Conditional survival among cancer patients in the United States","volume":"15","author":"Merrill","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.ejca.2013.10.019_b0105","series-title":"International classification of diseases for oncology","author":"Fritz","year":"2000"},{"key":"10.1016\/j.ejca.2013.10.019_b0110","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/ije\/22.3.369","article-title":"Completeness of cancer registration in Limburg, The Netherlands","volume":"22","author":"Schouten","year":"1993","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ejca.2013.10.019_b0115","series-title":"Instructions to IBM 650 programmers in processing survival computations","author":"Ederer","year":"1959"},{"key":"10.1016\/j.ejca.2013.10.019_b0120","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1200\/JCO.20.3.826","article-title":"Up-to-date long-term survival curves of patients with cancer by period analysis","volume":"20","author":"Brenner","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2013.10.019_b0125","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/(SICI)1097-0142(19961101)78:9<2004::AID-CNCR23>3.0.CO;2-#","article-title":"An alternative approach to monitoring cancer patient survival","volume":"78","author":"Brenner","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2013.10.019_b0130","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/annonc\/mdj139","article-title":"Higher long-term cancer survival rates in southeastern Netherlands using up-to-date period analysis","volume":"17","author":"Houterman","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2013.10.019_b0135","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1016\/j.ejca.2004.07.022","article-title":"Hybrid analysis for up-to-date long-term survival rates in cancer registries with delayed recording of incident cases","volume":"40","author":"Brenner","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2013.10.019_b0140","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1200\/JCO.2011.38.8561","article-title":"Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia","volume":"30","author":"Green","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2013.10.019_b0145","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1200\/JCO.2011.38.0584","article-title":"Superior outcome of women with stage I\/II cutaneous melanoma: pooled analysis of four European organisation for research and treatment of cancer phase III trials","volume":"30","author":"Joosse","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2013.10.019_b0150","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/jid.2010.354","article-title":"Gender differences in melanoma survival: female patients have a decreased risk of metastasis","volume":"131","author":"Joosse","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2013.10.019_b0155","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/annonc\/mdm498","article-title":"Superior survival of females among 10,538 Dutch melanoma patients is independent of Breslow thickness, histologic type and tumor site","volume":"19","author":"de Vries","year":"2008","journal-title":"Ann Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980491300957X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980491300957X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T04:31:15Z","timestamp":1716179475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095980491300957X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S095980491300957X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2013.10.019","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Conditional survival of malignant melanoma in The Netherlands: 1994\u20132008","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2013.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}